Global Blood Screening Market is Projected to Reach USD 3.3 Billion by 2024 from USD 2.2 Billion in 2019, at a CAGR of 8.7% - ResearchAndMarkets.com

DUBLIN--()--The "Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The blood screening market is projected to reach USD 3.3 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 8.7%.

Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market

Growth in this market is driven by the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens. Technological advancements and developing economies are expected to present opportunities for growth for players in the blood screening market. However, the need to reduce blood screening prices is a major factor in challenging market growth.

Nucleic Acid Testing (NAT) segment accounted for the larger share of the blood screening market, by technology, in 2018

The blood screening market, by technology, has been segmented into nucleic acid testing (NAT), enzyme-linked immunosorbent assays (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment dominates the blood screening market, by technology, primarily due to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies. Based on type, the blood screening market for NAT is segmented into transcription-mediated amplification (TMA) and real-time PCR. Among these, the TMA segment accounts for the larger market share due to the higher sensitivity of this assay.

Blood banks to register the highest growth in the blood screening market during the forecast period

Based on end-users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2018 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing the number of donations worldwide, and growth in government funding to charitable trusts.

North America will continue to dominate the blood screening market during the forecast period

Based on the region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

Key Topics Covered:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.4 Currency

1.5 Limitation

1.6 Stakeholders

2 Research Methodology

2.1 Research Data

2.2 Research Design

2.3 Secondary Data

2.4 Primary Data

2.5 Market Size Estimation

2.6 Market Breakdown and Data Triangulation

2.7 Assumptions for the Study

3 Executive Summary

4 Premium Insights

4.1 Blood Screening: Market Overview

4.2 Asia Pacific: Market Share, By End User & Country (2018)

4.3 Market, By Product & Service, 2019 Vs. 2024 (USD Million)

4.4 Geographical Snapshot of the Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

6 Blood Screening Market, By Product & Service

6.1 Introduction

6.2 Reagents & Kits

6.3 Instruments

6.4 Software & Services

7 Blood Screening Market, By Technology

7.1 Introduction

7.2 Nucleic Acid Testing (NAT)

7.3 Enzyme-Linked Immunosorbent Assays

7.4 Rapid Tests

7.5 Western Blot Assays

7.6 Next-Generation Sequencing

8 Blood Screening Market, By End User

8.1 Introduction

8.2 Blood Banks

8.3 Hospitals

9 Blood Screening Market, By Region

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 Latin America

9.6 Middle East & Africa

10 Competitive Landscape

10.1 Overview

10.2 Market Share Analysis, 2018

10.3 Competitive Scenario

10.4 Competitive Leadership Mapping (2019)

11 Company Profiles

11.1 Grifols

11.2 F. Hoffmann-La Roche

11.3 Abbott Laboratories

11.4 BioMrieux

11.5 Bio-Rad Laboratories

11.6 Becton, Dickson and Company

11.7 Danaher Corporation

11.8 Ortho Clinical Diagnostics

11.9 Siemens Healthineers

11.10 Thermo Fisher Scientific

11.11 DiaSorin

11.12 GE Healthcare

11.13 Merck KGaA

11.14 Perkinelmer

11.15 Bio-Techne

11.16 GFE

11.17 Trinity Biotech

11.18 J. Mitra Diagnostics Pvt. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/4oq5jb

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900